Brief: Satsuma Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering
17/09/2019 21:36
Satsuma Pharmaceuticals Inc STSA.O :
* SATSUMA PHARMACEUTICALS, INC. ANNOUNCES CLOSING OF INITIAL
PUBLIC OFFERING
Source text for Eikon: ID:nPn4cRB1Ba
Further company coverage: STSA.O
Recent news on Satsuma Pharmaceuticals
See all newsBrief: Satsuma Pharmaceuticals Announces FDA Acceptance Of 505(B)(2) NDA For Sts101, A Novel And Investigational Dihydroergotamine Nasal Powder Product For The Acute Treatment Of Migraine
Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
Brief: Satsuma Pharmaceuticals Says Received Letter Notifying Co Regained Compliance With Nasdaq
U.S. STOCKS ON THE MOVE-Alphabet Inc, BlackRock, Moderna
Satsuma Pharma soars on buyout deal from Japan's Shin Nippon